Sarcoidosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 9: | Line 9: | ||
== Prevalence == | == Prevalence == | ||
<span class="Apple-style-span" style="font-family: Cambria; font-size: 16px; ">Patients | |||
most commonly affected by sarcoidosis are 20-40 years of age.<sup>1</sup><span style="mso-spacerun:yes"> </span>Women are more affected than men (6.3 per 100,000; 5.9 per 100,000) listed respectively.<span style="mso-spacerun:yes"> | |||
</span>African Americans are the most diagnosed race in the United States at 4 x the diagnosis number for Caucasians (2.4%; 0.85%)<sup>4</sup>.<span style="mso-spacerun:yes"> </span>In the United Kingdom, 5-10/100,000 individuals are diagnosed with sarcoidosis.<span style="mso-spacerun:yes"> </span>It is the most common interstitial lung disorder in the west and has a high incidence in the Irish, West Indian, and Scandinavian people<sup>5</sup>.</span> | |||
<!--StartFragment--><!--EndFragment--> | |||
== Characteristics/Clinical Presentation == | == Characteristics/Clinical Presentation == |
Revision as of 22:31, 17 March 2011
Original Editors - Jordan Bormann from Bellarmine University's Pathophysiology of Complex Patient Problems project.
Lead Editors - Your name will be added here if you are a lead editor on this page. Read more.
Sarcoidosis (sar-coy-doe-sis) is a potentially life threatening disease with no known cause or cure. The duration of this disease varies and can last from only a few short months to several years. Often times, sarcoidosis is self-limiting needing no medicinal treatment. The primary manifestation of sarcoidosis includes inflammation of the lungs as well as many other bodily organs. About 90% of diagnosed cases are deemed to be pulmonary sarcoidosis. The pulmonary involvement affects the lungs by forming inflamed masses of tissue known as granulomas in the lung parenchyma (alveoli, bronchioles) and lymph nodes1,2. Results include stiffness of the lungs due to scar tissue formation causing decreased oxygen uptake and gas exchange in the bloodstream2. Other involvement of sarcoidosis can manifest itself as inflammation of the epithelial tissue, eyes, liver, spleen, heart, kidneys, central nervous system (CNS) and bones of the hands or feet1. Although this disease has not always been well known, cases have been recorded worldwide and are becoming increasingly more common3.
Prevalence[edit | edit source]
Patients most commonly affected by sarcoidosis are 20-40 years of age.1 Women are more affected than men (6.3 per 100,000; 5.9 per 100,000) listed respectively. African Americans are the most diagnosed race in the United States at 4 x the diagnosis number for Caucasians (2.4%; 0.85%)4. In the United Kingdom, 5-10/100,000 individuals are diagnosed with sarcoidosis. It is the most common interstitial lung disorder in the west and has a high incidence in the Irish, West Indian, and Scandinavian people5.
Characteristics/Clinical Presentation[edit | edit source]
add text here
Associated Co-morbidities[edit | edit source]
add text here
Medications[edit | edit source]
add text here
Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]
add text here
Etiology/Causes[edit | edit source]
add text here
Systemic Involvement[edit | edit source]
add text here
Medical Management (current best evidence)[edit | edit source]
add text here
Physical Therapy Management (current best evidence)[edit | edit source]
add text here
Alternative/Holistic Management (current best evidence)[edit | edit source]
add text here
Differential Diagnosis[edit | edit source]
add text here
Case Reports/ Case Studies[edit | edit source]
add links to case studies here (case studies should be added on new pages using the case study template)
Resources
[edit | edit source]
add appropriate resources here
Recent Related Research (from Pubmed)[edit | edit source]
see tutorial on Adding PubMed Feed
Failed to load RSS feed from http://eutils.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=14yXSIREv9VD-UHjYy-RRAqSlrEv8nOVmP55Z3ILaddKCUbMoo: Error parsing XML for RSS
References[edit | edit source]
see adding references tutorial.
Fuller KS, Goodman CC. Pathology implications for the physical therapist. 3rd ed. St. Louis: Saunders, 2009.
American Lung Association. Lung Diseases: sarcoidosis. http://www.lungusa.org/lung-disease/sarcoidosis/ (Accessed March 16,2011)
Foundation for Sarcoidosis research. Sarcoidosis: General Info, Symptoms, Diagnosis, Treatment. http://www.stopsarcoidosis.org/sarcoidosis/diseasefacts.htm (Accessed March 16, 2011)